Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating XW003 for weight management in adults with overweight or obesity; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• XW003

Snippet

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. | Conditions: Weight Management | Phase 3 | Status: COMPLETED